Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oxford Immunotec Global PLC

www.oxfordimmunotec.com

Latest From Houston Biotechnology Inc.

Dealmaking Styles of Regional Players

As dealmakers, Japanese and mid-sized European drug companies both tend to favor regional, rather than worldwide, agreements. But Europeans tend to pay more upfront, a reflection of the fact that they often prefer to use equity rather than simply cash in making their payments.
BioPharmaceutical North America
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Cytology
  • Laboratory Testing Services
  • Therapeutic Areas
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Oxford Immunotec Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Oxford Immunotec Global PLC
  • Senior Management
  • Peter Wrighton-Smith, PhD, CEO
    Richard Altieri, CFO
    Jeff Schroeder, Chief Commercial Officer
  • Contact Info
  • Oxford Immunotec Global PLC
    Phone: (44) 1235 442 780
    115D Innovation Dr., Milton Pk.
    Abingdon, OX14 4RZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register